Cohen Lawrence B Biogen Inc. Transaction History

Cohen Lawrence B

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 01, 2019	SELL	$219.29 - $241.72 $1.56 Million - $1.71 Million	-7,093 Closed	0 $0
Q1 2019 Apr 17, 2019	SELL	$216.71 - $338.96 $97,519 - $152,532	-450 Reduced 5.97%	7,093 $1.68 Million
Q4 2018 Jan 14, 2019	SELL	$278.5 - $352.75 $23,951 - $30,336	-86 Reduced 1.13%	7,543 $2.27 Million
Q3 2018 Oct 23, 2018	SELL	$293.51 - $383.83 $171,116 - $223,772	-583 Reduced 7.1%	7,629 $2.7 Million
Q2 2018 Jul 26, 2018	SELL	$257.52 - $306.91 $385,764 - $459,751	-1,498 Reduced 15.43%	8,212 $2.38 Million
Q1 2018 Apr 19, 2018	BUY	$260.13 - $367.91 $24,712 - $34,951	95 Added 0.99%	9,710 $2.66 Million
Q4 2017 Feb 06, 2018	SELL	$307.64 - $344.58 $19,996 - $22,397	-65 Reduced 0.67%	9,615 $3.06 Million
Q3 2017 Nov 03, 2017	BUY	$281.15 - $329.69 $2.72 Million - $3.19 Million	9,680	9,680 $3.03 Million

1,038

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Cohen Lawrence B, based on Form 13F filings with the SEC.

Stay updated on Cohen Lawrence B with notifications on news.